Beyond GLP-1: is GPCR poly-pharmacology the path forward to...

  • Main
  • 2018 / 06
  • Beyond GLP-1: is GPCR poly-pharmacology the path forward to...

Beyond GLP-1: is GPCR poly-pharmacology the path forward to treating metabolic diseases?

Sloop, Kyle W., Briere, Daniel A, Emmerson, Paul J, Willard, Francis S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
ACS Pharmacology & Translational Science
DOI:
10.1021/acsptsci.8b00009
Date:
June, 2018
File:
PDF, 491 KB
english, 2018
Conversion to is in progress
Conversion to is failed